Literature DB >> 23092211

Why does the G117H mutation considerably improve the activity of human butyrylcholinesterase against sarin? Insights from quantum mechanical/molecular mechanical free energy calculations.

Yuan Yao1, Junjun Liu, Chang-Guo Zhan.   

Abstract

Human butyrylcholinesterase (BChE) is recognized as the most promising bioscavenger for organophosphorus (OP) warfare nerve agents. The G117H mutant of human BChE has been identified as a potential catalytic bioscavenger with a remarkably improved activity against OP nerve agents such as sarin, but it still does not satisfy the clinical use. For further design of the higher-activity mutants against OP nerve agents, it is essential to understand how the G117H mutation improves the activity. The reaction mechanisms and the free energy profiles for spontaneous reactivation of wild-type BChE and its G117H mutant phosphorylated by sarin have been explored, in this study, by performing first-principles quantum mechanical/molecular mechanical free energy calculations, and the remarkable role of the G117H mutation on the activity has been elucidated. For both the wild-type and G117H mutant enzymes, H438 acts as a general base to initiate the spontaneous reactivation that consists of two reaction steps: the nucleophilic attack at the phosphorus by a water molecule and decomposition of the pentacoordinated phosphorus intermediate. The calculated overall free energy barriers, i.e., 30.2 and 23.9 kcal/mol for the wild type and G117H mutant, respectively, are in good agreement with available experimental kinetic data. On the basis of the calculated results, the mutated residue (H117 in the G117H mutant) cannot initiate the spontaneous reactivation as a general base. Instead, it skews the oxyanion hole and makes the phosphorus more open to the nucleophilic water molecule, resulting in a remarkable change in the rate-determining step and significantly improved catalytic activity of human BChE.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23092211      PMCID: PMC3499032          DOI: 10.1021/bi3009246

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  51 in total

1.  Retrospective detection of exposure to organophosphorus anti-cholinesterases: mass spectrometric analysis of phosphylated human butyrylcholinesterase.

Authors:  A Fidder; A G Hulst; D Noort; R de Ruiter; M J van der Schans; H P Benschop; J P Langenberg
Journal:  Chem Res Toxicol       Date:  2002-04       Impact factor: 3.739

2.  The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase.

Authors:  L Raveh; E Grauer; J Grunwald; E Cohen; Y Ashani
Journal:  Toxicol Appl Pharmacol       Date:  1997-07       Impact factor: 4.219

3.  The protein backbone makes important contributions to 4-oxalocrotonate tautomerase enzyme catalysis: understanding from theory and experiment.

Authors:  G Andrés Cisneros; Min Wang; Peter Silinski; Michael C Fitzgerald; Weitao Yang
Journal:  Biochemistry       Date:  2004-06-08       Impact factor: 3.162

4.  Catalytic mechanism and product specificity of the histone lysine methyltransferase SET7/9: an ab initio QM/MM-FE study with multiple initial structures.

Authors:  Po Hu; Yingkai Zhang
Journal:  J Am Chem Soc       Date:  2006-02-01       Impact factor: 15.419

5.  X-ray crystallographic snapshots of reaction intermediates in the G117H mutant of human butyrylcholinesterase, a nerve agent target engineered into a catalytic bioscavenger.

Authors:  Florian Nachon; Eugenie Carletti; Marielle Wandhammer; Yvain Nicolet; Lawrence M Schopfer; Patrick Masson; Oksana Lockridge
Journal:  Biochem J       Date:  2011-02-15       Impact factor: 3.857

6.  Identification of metabolites of nerve agent VX in serum collected from a victim.

Authors:  H Tsuchihashi; M Katagi; M Nishikawa; M Tatsuno
Journal:  J Anal Toxicol       Date:  1998-09       Impact factor: 3.367

7.  Definition of general topological equivalence in protein structures. A procedure involving comparison of properties and relationships through simulated annealing and dynamic programming.

Authors:  A Sali; T L Blundell
Journal:  J Mol Biol       Date:  1990-03-20       Impact factor: 5.469

8.  Quantitative analysis of O-isopropyl methylphosphonic acid in serum samples of Japanese citizens allegedly exposed to sarin: estimation of internal dosage.

Authors:  D Noort; A G Hulst; D H Platenburg; M Polhuijs; H P Benschop
Journal:  Arch Toxicol       Date:  1998-10       Impact factor: 5.153

9.  Functional and structural changes due to a serine to alanine mutation in the active-site flap of enolase.

Authors:  Russell R Poyner; Todd M Larsen; Se-Wei Wong; George H Reed
Journal:  Arch Biochem Biophys       Date:  2002-05-15       Impact factor: 4.013

10.  Design and expression of organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase.

Authors:  C B Millard; O Lockridge; C A Broomfield
Journal:  Biochemistry       Date:  1995-12-12       Impact factor: 3.162

View more
  12 in total

1.  Fundamental reaction pathway and free energy profile for butyrylcholinesterase-catalyzed hydrolysis of heroin.

Authors:  Yan Qiao; Keli Han; Chang-Guo Zhan
Journal:  Biochemistry       Date:  2013-08-30       Impact factor: 3.162

2.  Catalytic Reaction Mechanism for Drug Metabolism in Human Carboxylesterase-1: Cocaine Hydrolysis Pathway.

Authors:  Jianzhuang Yao; Xiabin Chen; Fang Zheng; Chang-Guo Zhan
Journal:  Mol Pharm       Date:  2018-08-10       Impact factor: 4.939

Review 3.  Sarin (GB, O-isopropyl methylphosphonofluoridate) neurotoxicity: critical review.

Authors:  Mohamed B Abou-Donia; Briana Siracuse; Natasha Gupta; Ashly Sobel Sokol
Journal:  Crit Rev Toxicol       Date:  2016-10-05       Impact factor: 5.635

4.  Engineering Dynamic Surface Peptide Networks on ButyrylcholinesteraseG117H for Enhanced Organophosphosphorus Anticholinesterase Catalysis.

Authors:  Kirstin P Hester; Krishna Bhattarai; Haobo Jiang; Pratul K Agarwal; Carey Pope
Journal:  Chem Res Toxicol       Date:  2019-08-28       Impact factor: 3.739

5.  Fundamental reaction pathway and free energy profile of proteasome inhibition by syringolin A (SylA).

Authors:  Donghui Wei; Mingsheng Tang; Chang-Guo Zhan
Journal:  Org Biomol Chem       Date:  2015-06-28       Impact factor: 3.876

6.  Catalytic Mechanisms for Cofactor-Free Oxidase-Catalyzed Reactions: Reaction Pathways of Uricase-Catalyzed Oxidation and Hydration of Uric Acid.

Authors:  Donghui Wei; Xiaoqin Huang; Yan Qiao; Jingjing Rao; Lu Wang; Fei Liao; Chang-Guo Zhan
Journal:  ACS Catal       Date:  2017-06-15       Impact factor: 13.084

7.  Reaction pathways and free energy profiles for cholinesterase-catalyzed hydrolysis of 6-monoacetylmorphine.

Authors:  Yan Qiao; Keli Han; Chang-Guo Zhan
Journal:  Org Biomol Chem       Date:  2014-04-14       Impact factor: 3.876

8.  Catalytic mechanism of cytochrome P450 for N-methylhydroxylation of nicotine: reaction pathways and regioselectivity of the enzymatic nicotine oxidation.

Authors:  Dongmei Li; Xiaoqin Huang; Jianping Lin; Chang-Guo Zhan
Journal:  Dalton Trans       Date:  2013-01-09       Impact factor: 4.390

9.  Unexpected Reaction Pathway for butyrylcholinesterase-catalyzed inactivation of "hunger hormone" ghrelin.

Authors:  Jianzhuang Yao; Yaxia Yuan; Fang Zheng; Chang-Guo Zhan
Journal:  Sci Rep       Date:  2016-02-29       Impact factor: 4.379

10.  Development of organophosphate hydrolase activity in a bacterial homolog of human cholinesterase.

Authors:  Patricia M Legler; Susanne M Boisvert; Jaimee R Compton; Charles B Millard
Journal:  Front Chem       Date:  2014-07-16       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.